Retinoic acid and TGF-β signalling cooperate to overcome MYCN-induced retinoid resistance
| dc.contributor.author | Duffy, David J. | |
| dc.contributor.author | Krstic, Aleksandar | |
| dc.contributor.author | Halasz, Melinda | |
| dc.contributor.author | Schwarzl, Thomas | |
| dc.contributor.author | Konietzny, Anja | |
| dc.contributor.author | Iljin, Kristiina | |
| dc.contributor.author | Higgins, Desmond G. | |
| dc.contributor.author | Kolch, Walter | |
| dc.date.accessioned | 2017-04-27T07:51:06Z | |
| dc.date.available | 2017-04-27T07:51:06Z | |
| dc.date.issued | 2017 | eng |
| dc.description.abstract | Retinoid therapy is widely employed in clinical oncology to differentiate malignant cells into their more benign counterparts. However, certain high-risk cohorts, such as patients with MYCN-amplified neuroblastoma, are innately resistant to retinoid therapy. Therefore, we employed a precision medicine approach to globally profile the retinoid signalling response and to determine how an excess of cellular MYCN antagonises these signalling events to prevent differentiation and confer resistance. | eng |
| dc.description.version | published | eng |
| dc.identifier.doi | 10.1186/s13073-017-0407-3 | eng |
| dc.identifier.pmid | 28187790 | eng |
| dc.identifier.ppn | 487006895 | |
| dc.identifier.uri | https://kops.uni-konstanz.de/handle/123456789/38631 | |
| dc.language.iso | eng | eng |
| dc.rights | Attribution 4.0 International | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.subject.ddc | 570 | eng |
| dc.title | Retinoic acid and TGF-β signalling cooperate to overcome MYCN-induced retinoid resistance | eng |
| dc.type | JOURNAL_ARTICLE | eng |
| dspace.entity.type | Publication | |
| kops.citation.bibtex | @article{Duffy2017Retin-38631,
year={2017},
doi={10.1186/s13073-017-0407-3},
title={Retinoic acid and TGF-β signalling cooperate to overcome MYCN-induced retinoid resistance},
number={1},
volume={9},
journal={Genome Medicine},
author={Duffy, David J. and Krstic, Aleksandar and Halasz, Melinda and Schwarzl, Thomas and Konietzny, Anja and Iljin, Kristiina and Higgins, Desmond G. and Kolch, Walter},
note={Article Number: 15}
} | |
| kops.citation.iso690 | DUFFY, David J., Aleksandar KRSTIC, Melinda HALASZ, Thomas SCHWARZL, Anja KONIETZNY, Kristiina ILJIN, Desmond G. HIGGINS, Walter KOLCH, 2017. Retinoic acid and TGF-β signalling cooperate to overcome MYCN-induced retinoid resistance. In: Genome Medicine. 2017, 9(1), 15. eISSN 1756-994X. Available under: doi: 10.1186/s13073-017-0407-3 | deu |
| kops.citation.iso690 | DUFFY, David J., Aleksandar KRSTIC, Melinda HALASZ, Thomas SCHWARZL, Anja KONIETZNY, Kristiina ILJIN, Desmond G. HIGGINS, Walter KOLCH, 2017. Retinoic acid and TGF-β signalling cooperate to overcome MYCN-induced retinoid resistance. In: Genome Medicine. 2017, 9(1), 15. eISSN 1756-994X. Available under: doi: 10.1186/s13073-017-0407-3 | eng |
| kops.citation.rdf | <rdf:RDF
xmlns:dcterms="http://purl.org/dc/terms/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
xmlns:bibo="http://purl.org/ontology/bibo/"
xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
xmlns:foaf="http://xmlns.com/foaf/0.1/"
xmlns:void="http://rdfs.org/ns/void#"
xmlns:xsd="http://www.w3.org/2001/XMLSchema#" >
<rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/38631">
<dc:contributor>Iljin, Kristiina</dc:contributor>
<dc:contributor>Schwarzl, Thomas</dc:contributor>
<dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-04-27T07:51:06Z</dcterms:available>
<dc:creator>Halasz, Melinda</dc:creator>
<dc:contributor>Duffy, David J.</dc:contributor>
<dcterms:abstract xml:lang="eng">Retinoid therapy is widely employed in clinical oncology to differentiate malignant cells into their more benign counterparts. However, certain high-risk cohorts, such as patients with MYCN-amplified neuroblastoma, are innately resistant to retinoid therapy. Therefore, we employed a precision medicine approach to globally profile the retinoid signalling response and to determine how an excess of cellular MYCN antagonises these signalling events to prevent differentiation and confer resistance.</dcterms:abstract>
<dc:creator>Iljin, Kristiina</dc:creator>
<dcterms:title>Retinoic acid and TGF-β signalling cooperate to overcome MYCN-induced retinoid resistance</dcterms:title>
<dc:creator>Duffy, David J.</dc:creator>
<dcterms:issued>2017</dcterms:issued>
<dc:language>eng</dc:language>
<dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
<dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2017-04-27T07:51:06Z</dc:date>
<dc:contributor>Halasz, Melinda</dc:contributor>
<dc:contributor>Krstic, Aleksandar</dc:contributor>
<dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/38631/1/Duffy_0-399124.pdf"/>
<dcterms:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/>
<dc:creator>Kolch, Walter</dc:creator>
<void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
<dc:creator>Schwarzl, Thomas</dc:creator>
<dc:creator>Higgins, Desmond G.</dc:creator>
<dc:creator>Krstic, Aleksandar</dc:creator>
<dc:contributor>Higgins, Desmond G.</dc:contributor>
<foaf:homepage rdf:resource="http://localhost:8080/"/>
<dc:creator>Konietzny, Anja</dc:creator>
<dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/38631/1/Duffy_0-399124.pdf"/>
<dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
<dc:contributor>Konietzny, Anja</dc:contributor>
<dc:contributor>Kolch, Walter</dc:contributor>
<dc:rights>Attribution 4.0 International</dc:rights>
<bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/38631"/>
</rdf:Description>
</rdf:RDF> | |
| kops.description.openAccess | openaccessgold | eng |
| kops.identifier.nbn | urn:nbn:de:bsz:352-0-399124 | |
| kops.sourcefield | Genome Medicine. 2017, <b>9</b>(1), 15. eISSN 1756-994X. Available under: doi: 10.1186/s13073-017-0407-3 | deu |
| kops.sourcefield.plain | Genome Medicine. 2017, 9(1), 15. eISSN 1756-994X. Available under: doi: 10.1186/s13073-017-0407-3 | deu |
| kops.sourcefield.plain | Genome Medicine. 2017, 9(1), 15. eISSN 1756-994X. Available under: doi: 10.1186/s13073-017-0407-3 | eng |
| relation.isAuthorOfPublication | 2384609d-44f9-42ae-b98e-dff0d6b79d84 | |
| relation.isAuthorOfPublication.latestForDiscovery | 2384609d-44f9-42ae-b98e-dff0d6b79d84 | |
| source.bibliographicInfo.articleNumber | 15 | eng |
| source.bibliographicInfo.issue | 1 | eng |
| source.bibliographicInfo.volume | 9 | eng |
| source.identifier.eissn | 1756-994X | eng |
| source.periodicalTitle | Genome Medicine | eng |
Dateien
Originalbündel
1 - 1 von 1
Vorschaubild nicht verfügbar
- Name:
- Duffy_0-399124.pdf
- Größe:
- 3.05 MB
- Format:
- Adobe Portable Document Format
- Beschreibung:
Lizenzbündel
1 - 1 von 1
Vorschaubild nicht verfügbar
- Name:
- license.txt
- Größe:
- 3.88 KB
- Format:
- Item-specific license agreed upon to submission
- Beschreibung:

